Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Triple Negative Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03562637
What this trial is testing

Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

Who this might be right for
Triple Negative Breast Cancer
OBI Pharma, Inc 575
Testing effectiveness (Phase 2)Looking for participantsNCT06508216
What this trial is testing

Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05215106
What this trial is testing

Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)

Who this might be right for
Early Small (cT1N0) Triple Negative Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 200
Not applicableNot Yet RecruitingNCT07187674
What this trial is testing

The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and Paclitaxel

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Harbin Medical University 20
Testing effectiveness (Phase 2)Study completedNCT07143097
What this trial is testing

Capecitabine as Maintenance Therapy vs Observation in Early-stage Triple-negative Breast Cancer

Who this might be right for
Triple -Negative Breast Cancer
Beni-Suef University 80
Testing effectiveness (Phase 2)Looking for participantsNCT06078384
What this trial is testing

Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC

Who this might be right for
Triple-negative Breast Cancer
UNICANCER 354
Large-scale testing (Phase 3)Not Yet RecruitingNCT07178730
What this trial is testing

NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer

Who this might be right for
Breast CancerTriple-negative Breast Cancer
Women's Cancer Study Group GmbH 765
Testing effectiveness (Phase 2)Looking for participantsNCT07327021
What this trial is testing

MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC

Who this might be right for
TNBC, Triple Negative Breast CancerEarly Breast Cancer
Tel-Aviv Sourasky Medical Center 54
Large-scale testing (Phase 3)Study completedNCT04613674
What this trial is testing

Camrelizumab Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 441
Testing effectiveness (Phase 2)Looking for participantsNCT04768426
What this trial is testing

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerBreast Cancer
Stanford University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06404736
What this trial is testing

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer

Who this might be right for
Early Breast CancerNeoadjuvant TherapyTNBC, Triple Negative Breast Cancer
Fudan University 73
Large-scale testing (Phase 3)Looking for participantsNCT06606730
What this trial is testing

Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer

Who this might be right for
Breast CancersTriple Negative Breast Cancer (TNBC)
UNICANCER 2,454
Not applicableActive Not RecruitingNCT06782698
What this trial is testing

Home-Based Exercise Program During Neoadjuvant Treatment to Improve Fatigue and Quality of Life in Early HER2-Positive and Triple-Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer (TNBC)HER2-Positive Breast CancerEarly Breast Cancer+2 more
Centro Hospitalar Universitário de Santo António 50
Not applicableNot Yet RecruitingNCT07687446
What this trial is testing

Performance of Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early Triple-Negative Breast Cancer

Who this might be right for
Breast Cancer (Triple Negative Breast Cancer (TNBC))
Assistance Publique - Hôpitaux de Paris 100
Large-scale testing (Phase 3)Looking for participantsNCT05929768
What this trial is testing

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+2 more
SWOG Cancer Research Network 2,400
Very early researchEnded earlyNCT04102618
What this trial is testing

A Window-of-opportunity Study of Pelareorep in Early Breast Cancer

Who this might be right for
Breast Cancer
Oncolytics Biotech 26
Testing effectiveness (Phase 2)UnknownNCT03145961
What this trial is testing

A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Institute of Cancer Research, United Kingdom 208
Testing effectiveness (Phase 2)Looking for participantsNCT05464082
What this trial is testing

Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC

Who this might be right for
Breast Cancer Recurrent
University of Utah 80
Testing effectiveness (Phase 2)Looking for participantsNCT06768931
What this trial is testing

Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer (TNBC)Early Stage Breast Cancer+2 more
Sun Yat-sen University 192
Not applicableLooking for participantsNCT06328465
What this trial is testing

FREEDOM: REsonance for Early Detection Of Breast Cancer Metastases

Who this might be right for
Invasive Breast CancerHER2-positive Breast CancerTriple Negative Breast Cancer
European Institute of Oncology 145
Next Page